Fingerprint
Dive into the research topics of 'Nimotuzumab provides survival benefit to patients with inoperable advanced squamous cell carcinoma of the head and neck: A randomized, open-label, phase IIb, 5-year study in Indian patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically